Liqiang Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Liqiang Yu has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Aisong Guo
Department of Rehabilitation Medicine, Affiliated Hospital of Nantong University, Nantong 226001, PR China
1 shared publication- Cuiling Shen
Xiamen Medical College, Xiamen, China
1 shared publication Fang Liu
Nursing College, Fujian University of Traditional Chinese Medicine, Fuzhou, China
1 shared publication- Fang Liu
Fujian University of Traditional Chinese Medicine
1 shared publication Jiaying Guo
Nursing College Fujian University of Traditional Chinese Medicine Fuzhou China
1 shared publicationJunying Chen
Fujian Provincial Hospital, Fuzhou, China
1 shared publication
Latest Publications
- 29 August 2021
- Published by Wiley in Journal of Clinical Nursing
- Vol. 31 (9-10) , 1136-1148
The effects of computer‐assisted cognitive rehabilitation on cognitive impairment after stroke: A systematic review and meta‐analysis
Objectives: To determine the effectiveness of computer‐assisted cognitive rehabilitation in improving cognitive function in patients with post‐stroke cognitive impairment.Background: In recent years, computer‐assisted cognitive rehabilitation has been accepted as a good substitute or supplement for traditional cognitive rehabilitation. Some clinical randomised controlled trials have been carried out, but no relevant systematic evaluations have been performed. Therefore, we conducted a systematic review of studies involving computer‐assisted cognitive rehabilitation to provide evidence‐based data for its promotion and application.Methods: Nine databases (Cochrane Library, PubMed, Web of Science, Embase, OVID, Wanfang Data, CNKI, VIP and SinoMed databases) were systematically searched. Randomised controlled trials that assessed computer‐assisted cognitive rehabilitation for patients with post‐stroke cognitive impairment were included. Two reviewers appraised the risks of bias through the Cochrane Collaboration's tool and performed the meta‐analysis, including the assessment of heterogeneity. We follow the PRISMA 2020 guidelines.Results: Thirty‐two studies comprising 1837 participants were included. Compared with conventional therapy alone, the addition of computer‐assisted cognitive rehabilitation significantly improved the global cognition of patients, evaluated using the Montreal cognitive assessment, mini‐mental state examination and Loewenstein occupational therapy cognitive assessment (p < .01 for all tests). The therapy also significantly improved activities of daily living, assessed using the Barthel index, modified Barthel index and functional independence measure (p < .05 for all tests).Conclusion: Computer‐assisted cognitive rehabilitation significantly improved the cognitive function and activities of daily living of patients with post‐stroke cognitive impairment.Relevance to clinical practice: Computer‐assisted cognitive rehabilitation can be a valuable technique for cognitive rehabilitation after stroke. It is advantageous for improving patient cognition and restoring the overall functional state of patients. Moreover, the research findings can provide suggestions and inspiration for researchers to implement the proposal, which is conducive to the design of more rigorous and high‐quality randomised controlled trials.
- 29 August 2021
- Published by Wiley in Journal of Clinical Nursing
- Vol. 31 (9-10) , 1136-1148
The effects of computer‐assisted cognitive rehabilitation on cognitive impairment after stroke: A systematic review and meta‐analysis
Objectives: To determine the effectiveness of computer‐assisted cognitive rehabilitation in improving cognitive function in patients with post‐stroke cognitive impairment.Background: In recent years, computer‐assisted cognitive rehabilitation has been accepted as a good substitute or supplement for traditional cognitive rehabilitation. Some clinical randomised controlled trials have been carried out, but no relevant systematic evaluations have been performed. Therefore, we conducted a systematic review of studies involving computer‐assisted cognitive rehabilitation to provide evidence‐based data for its promotion and application.Methods: Nine databases (Cochrane Library, PubMed, Web of Science, Embase, OVID, Wanfang Data, CNKI, VIP and SinoMed databases) were systematically searched. Randomised controlled trials that assessed computer‐assisted cognitive rehabilitation for patients with post‐stroke cognitive impairment were included. Two reviewers appraised the risks of bias through the Cochrane Collaboration's tool and performed the meta‐analysis, including the assessment of heterogeneity. We follow the PRISMA 2020 guidelines.Results: Thirty‐two studies comprising 1837 participants were included. Compared with conventional therapy alone, the addition of computer‐assisted cognitive rehabilitation significantly improved the global cognition of patients, evaluated using the Montreal cognitive assessment, mini‐mental state examination and Loewenstein occupational therapy cognitive assessment (p < .01 for all tests). The therapy also significantly improved activities of daily living, assessed using the Barthel index, modified Barthel index and functional independence measure (p < .05 for all tests).Conclusion: Computer‐assisted cognitive rehabilitation significantly improved the cognitive function and activities of daily living of patients with post‐stroke cognitive impairment.Relevance to clinical practice: Computer‐assisted cognitive rehabilitation can be a valuable technique for cognitive rehabilitation after stroke. It is advantageous for improving patient cognition and restoring the overall functional state of patients. Moreover, the research findings can provide suggestions and inspiration for researchers to implement the proposal, which is conducive to the design of more rigorous and high‐quality randomised controlled trials.
- 4 November 2020
- Published by SAGE Publications in Clinical Rehabilitation
- Vol. 35 (4) , 492-505
Systematic review and meta-analysis of randomized controlled trials assessing the impact of Baduanjin exercise on cognition and memory in patients with mild cognitive impairment
Objective: To determine the effectiveness of Baduanjin exercise in improving cognition and memory in patients with mild cognitive impairment. Data sources: Relevant English- and Chinese-language studies published until 15th September 2020 were retrieved from the PubMed, Web of Science, Cochrane Library, Embase, EBSCOhost, OVID, National Knowledge Infrastructure, WANFANG DATA, VIP Information, and SinoMed databases. Review methods: Randomized controlled trials assessing Baduanjin exercise in patients with mild cognitive impairment were included. Two researchers independently identified eligible studies and extracted data. Risk-of-bias assessment was performed using the Cochrane Risk of Bias Tool. Results: This study included 16 randomized controlled trials (1054 participants) from China that used Chinese versions of standardized tests. Most studies had no significant bias, and only one study had a high risk of bias in the random allocation category. Compared with conventional therapy alone, Baduanjin plus conventional therapy significantly improved the Montreal Cognitive Assessment and Mini-Mental State Examination scores after 6 months of treatment ( P < 0.00001 for both), significantly decreased the tau/Aβ1–42 ratio in the cerebrospinal fluid ( P < 0.00001), and significantly improved some dimensional scores on the Wechsler Memory Scale and the auditory verbal learning test scores at 6 months ( P < 0.05 for all). Conclusion: Compared with conventional therapy, Baduanjin plus conventional therapy significantly improved cognitive and memory function in patients with mild cognitive impairment.
- 4 November 2020
- Published by SAGE Publications in Clinical Rehabilitation
- Vol. 35 (4) , 492-505
Systematic review and meta-analysis of randomized controlled trials assessing the impact of Baduanjin exercise on cognition and memory in patients with mild cognitive impairment
Objective: To determine the effectiveness of Baduanjin exercise in improving cognition and memory in patients with mild cognitive impairment. Data sources: Relevant English- and Chinese-language studies published until 15th September 2020 were retrieved from the PubMed, Web of Science, Cochrane Library, Embase, EBSCOhost, OVID, National Knowledge Infrastructure, WANFANG DATA, VIP Information, and SinoMed databases. Review methods: Randomized controlled trials assessing Baduanjin exercise in patients with mild cognitive impairment were included. Two researchers independently identified eligible studies and extracted data. Risk-of-bias assessment was performed using the Cochrane Risk of Bias Tool. Results: This study included 16 randomized controlled trials (1054 participants) from China that used Chinese versions of standardized tests. Most studies had no significant bias, and only one study had a high risk of bias in the random allocation category. Compared with conventional therapy alone, Baduanjin plus conventional therapy significantly improved the Montreal Cognitive Assessment and Mini-Mental State Examination scores after 6 months of treatment ( P < 0.00001 for both), significantly decreased the tau/Aβ1–42 ratio in the cerebrospinal fluid ( P < 0.00001), and significantly improved some dimensional scores on the Wechsler Memory Scale and the auditory verbal learning test scores at 6 months ( P < 0.05 for all). Conclusion: Compared with conventional therapy, Baduanjin plus conventional therapy significantly improved cognitive and memory function in patients with mild cognitive impairment.
- Open Access
- 1 June 2019
- Published by Elsevier in Neuroscience
- Vol. 408, 349-360
Macrophage Migration Inhibitory Factor Promotes Chemotaxis of Astrocytes through Regulation of Cholesterol 25-Hydroxylase Following Rat Spinal Cord Injury
- 1 June 2019
- Published by Elsevier in Neuroscience
- Vol. 408, 349-360
Open AccessMacrophage Migration Inhibitory Factor Promotes Chemotaxis of Astrocytes through Regulation of Cholesterol 25-Hydroxylase Following Rat Spinal Cord Injury